---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-23-000053"
form_type: "8-K"
ticker: "CHE"
cik: "0000019584"
company_name: "CHEMED CORP"
filed_at: "2023-02-23T23:59:59+00:00"
generated_at: "2026-06-19T03:24:12.669008+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Chemed Q4 2022 adjusted EPS $5.39 (+2.7% YoY); guides 2023 adjusted EPS $20.75-$21.10

## Summary
- Consolidated revenue $547M (+1.0% YoY); GAAP diluted EPS $4.13; adjusted diluted EPS $5.39.
- VITAS net patient revenue $308M (-2.5%); ADC 17,434 (-2.8%); admissions -8.7%; adjusted EBITDA margin 19.8% (-189bps).
- Roto-Rooter revenue $239M (+6.1%); adjusted EBITDA $69.3M (+11.4%); margin 29.0% (+138bps).
- 2023 guidance: VITAS revenue +6-7%, ADC +3.5-4%; Roto-Rooter revenue +5-5.5%; adjusted EPS $20.75-$21.10.
- Share repurchases: 25,000 shares for $13.0M in Q4; $88M remaining authorization.

## SEC filing metadata
- accession: 0001562762-23-000053
- form_type: 8-K
- ticker: CHE
- cik: 0000019584
- company_name: CHEMED CORP
- filed_at: 2023-02-23T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/19584/000156276223000053/0001562762-23-000053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/19584/000156276223000053/che-20230223x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-23-000053
- JSON: https://secwatch.observer/filing/0001562762-23-000053.json
- Plain text: https://secwatch.observer/filing/0001562762-23-000053.txt

## Key facts
- Earnings Releases
  CHEMED CORP reported the fourth quarter ended December 31, 2022 results: revenue $547 million, EPS $4.13. Guidance initiated.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $547 million
  - EPS: $4.13
  - Guidance: initiated
  - Result: reported results
  source text: Chemed Corporation (Chemed) (NYSE: CHE ), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2022, versus the comparable prior-year period, as follows:  Consolidated operating results: · Revenue increased 1.0% to $547 million · GAAP Diluted Earnings-per-Share (EPS) of $4.13 · Adjusted Diluted EPS of $5.39
  evidence_url: https://www.sec.gov/Archives/edgar/data/19584/000156276223000053/0001562762-23-000053-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.